Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 259

1.

Roundtable discussion: Dietary fats in prevention of atherosclerotic cardiovascular disease.

Severson T, Kris-Etherton PM, Robinson JG, Guyton JR.

J Clin Lipidol. 2018 May - Jun;12(3):574-582. doi: 10.1016/j.jacl.2018.05.006. Epub 2018 May 14. Review.

PMID:
29880281
2.

From Bottleneck to Breakthrough: Urbanization and the Future of Biodiversity Conservation.

Sanderson EW, Walston J, Robinson JG.

Bioscience. 2018 Jun 1;68(6):412-426. doi: 10.1093/biosci/biy039. Epub 2018 Apr 22.

3.

The Call for Precision Health Trials in Older Adults: One Size Does Not Fit All.

Robinson JG, Hernandez AF.

J Am Coll Cardiol. 2018 Jun 5;71(22):2537-2539. doi: 10.1016/j.jacc.2018.03.503. No abstract available.

PMID:
29852977
4.

Efficacy and Safety of Alirocumab in Individuals with Diabetes Mellitus: Pooled Analyses from Five Placebo-Controlled Phase 3 Studies.

Ginsberg HN, Farnier M, Robinson JG, Cannon CP, Sattar N, Baccara-Dinet MT, Letierce A, Bujas-Bobanovic M, Louie MJ, Colhoun HM.

Diabetes Ther. 2018 Jun;9(3):1317-1334. doi: 10.1007/s13300-018-0439-8. Epub 2018 May 19.

5.

Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis.

Navarese EP, Robinson JG, Kowalewski M, Kolodziejczak M, Andreotti F, Bliden K, Tantry U, Kubica J, Raggi P, Gurbel PA.

JAMA. 2018 Apr 17;319(15):1566-1579. doi: 10.1001/jama.2018.2525. Review.

PMID:
29677301
6.

Optimizing Statins and Ezetimibe in Guideline-Focused Management.

Bin Abdulhak AA, Robinson JG.

Cardiol Clin. 2018 May;36(2):221-223. doi: 10.1016/j.ccl.2017.12.003. Review.

PMID:
29609751
7.

Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) Registry.

Navar AM, Peterson ED, Li S, Robinson JG, Roger VL, Goldberg AC, Virani S, Wilson PWF, Nanna MG, Lee LV, Elassal J, Wang TY.

Circ Cardiovasc Qual Outcomes. 2018 Mar;11(3):e004249. doi: 10.1161/CIRCOUTCOMES.117.004249. No abstract available.

PMID:
29545393
8.

Temporal Trends of High-Intensity Statin Therapy Among Veterans Treated With Percutaneous Coronary Intervention.

Bin Abdulhak AA, Vaughan-Sarrzin M, Kaboli P, Horwitz PA, Mosher H, Sigurdsson G, Walker NE, Wallace R, Robinson JG.

J Am Heart Assoc. 2018 Mar 4;7(5). pii: e007370. doi: 10.1161/JAHA.117.007370.

9.

The exceptional value of intact forest ecosystems.

Watson JEM, Evans T, Venter O, Williams B, Tulloch A, Stewart C, Thompson I, Ray JC, Murray K, Salazar A, McAlpine C, Potapov P, Walston J, Robinson JG, Painter M, Wilkie D, Filardi C, Laurance WF, Houghton RA, Maxwell S, Grantham H, Samper C, Wang S, Laestadius L, Runting RK, Silva-Chávez GA, Ervin J, Lindenmayer D.

Nat Ecol Evol. 2018 Apr;2(4):599-610. doi: 10.1038/s41559-018-0490-x. Epub 2018 Feb 26. Review.

PMID:
29483681
10.

A Large-Scale Multi-ancestry Genome-wide Study Accounting for Smoking Behavior Identifies Multiple Significant Loci for Blood Pressure.

Sung YJ, Winkler TW, de Las Fuentes L, Bentley AR, Brown MR, Kraja AT, Schwander K, Ntalla I, Guo X, Franceschini N, Lu Y, Cheng CY, Sim X, Vojinovic D, Marten J, Musani SK, Li C, Feitosa MF, Kilpeläinen TO, Richard MA, Noordam R, Aslibekyan S, Aschard H, Bartz TM, Dorajoo R, Liu Y, Manning AK, Rankinen T, Smith AV, Tajuddin SM, Tayo BO, Warren HR, Zhao W, Zhou Y, Matoba N, Sofer T, Alver M, Amini M, Boissel M, Chai JF, Chen X, Divers J, Gandin I, Gao C, Giulianini F, Goel A, Harris SE, Hartwig FP, Horimoto ARVR, Hsu FC, Jackson AU, Kähönen M, Kasturiratne A, Kühnel B, Leander K, Lee WJ, Lin KH, 'an Luan J, McKenzie CA, Meian H, Nelson CP, Rauramaa R, Schupf N, Scott RA, Sheu WHH, Stančáková A, Takeuchi F, van der Most PJ, Varga TV, Wang H, Wang Y, Ware EB, Weiss S, Wen W, Yanek LR, Zhang W, Zhao JH, Afaq S, Alfred T, Amin N, Arking D, Aung T, Barr RG, Bielak LF, Boerwinkle E, Bottinger EP, Braund PS, Brody JA, Broeckel U, Cabrera CP, Cade B, Caizheng Y, Campbell A, Canouil M, Chakravarti A; CHARGE Neurology Working Group, Chauhan G, Christensen K, Cocca M; COGENT-Kidney Consortium, Collins FS, Connell JM, de Mutsert R, de Silva HJ, Debette S, Dörr M, Duan Q, Eaton CB, Ehret G, Evangelou E, Faul JD, Fisher VA, Forouhi NG, Franco OH, Friedlander Y, Gao H; GIANT Consortium, Gigante B, Graff M, Gu CC, Gu D, Gupta P, Hagenaars SP, Harris TB, He J, Heikkinen S, Heng CK, Hirata M, Hofman A, Howard BV, Hunt S, Irvin MR, Jia Y, Joehanes R, Justice AE, Katsuya T, Kaufman J, Kerrison ND, Khor CC, Koh WP, Koistinen HA, Komulainen P, Kooperberg C, Krieger JE, Kubo M, Kuusisto J, Langefeld CD, Langenberg C, Launer LJ, Lehne B, Lewis CE, Li Y; Lifelines Cohort Study, Lim SH, Lin S, Liu CT, Liu J, Liu J, Liu K, Liu Y, Loh M, Lohman KK, Long J, Louie T, Mägi R, Mahajan A, Meitinger T, Metspalu A, Milani L, Momozawa Y, Morris AP, Mosley TH Jr, Munson P, Murray AD, Nalls MA, Nasri U, Norris JM, North K, Ogunniyi A, Padmanabhan S, Palmas WR, Palmer ND, Pankow JS, Pedersen NL, Peters A, Peyser PA, Polasek O, Raitakari OT, Renström F, Rice TK, Ridker PM, Robino A, Robinson JG, Rose LM, Rudan I, Sabanayagam C, Salako BL, Sandow K, Schmidt CO, Schreiner PJ, Scott WR, Seshadri S, Sever P, Sitlani CM, Smith JA, Snieder H, Starr JM, Strauch K, Tang H, Taylor KD, Teo YY, Tham YC, Uitterlinden AG, Waldenberger M, Wang L, Wang YX, Wei WB, Williams C, Wilson G, Wojczynski MK, Yao J, Yuan JM, Zonderman AB, Becker DM, Boehnke M, Bowden DW, Chambers JC, Chen YI, de Faire U, Deary IJ, Esko T, Farrall M, Forrester T, Franks PW, Freedman BI, Froguel P, Gasparini P, Gieger C, Horta BL, Hung YJ, Jonas JB, Kato N, Kooner JS, Laakso M, Lehtimäki T, Liang KW, Magnusson PKE, Newman AB, Oldehinkel AJ, Pereira AC, Redline S, Rettig R, Samani NJ, Scott J, Shu XO, van der Harst P, Wagenknecht LE, Wareham NJ, Watkins H, Weir DR, Wickremasinghe AR, Wu T, Zheng W, Kamatani Y, Laurie CC, Bouchard C, Cooper RS, Evans MK, Gudnason V, Kardia SLR, Kritchevsky SB, Levy D, O'Connell JR, Psaty BM, van Dam RM, Sims M, Arnett DK, Mook-Kanamori DO, Kelly TN, Fox ER, Hayward C, Fornage M, Rotimi CN, Province MA, van Duijn CM, Tai ES, Wong TY, Loos RJF, Reiner AP, Rotter JI, Zhu X, Bierut LJ, Gauderman WJ, Caulfield MJ, Elliott P, Rice K, Munroe PB, Morrison AC, Cupples LA, Rao DC, Chasman DI.

Am J Hum Genet. 2018 Mar 1;102(3):375-400. doi: 10.1016/j.ajhg.2018.01.015. Epub 2018 Feb 15.

PMID:
29455858
11.

Chart validation of inpatient ICD-9-CM administrative diagnosis codes for acute myocardial infarction (AMI) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database.

Ammann EM, Schweizer ML, Robinson JG, Eschol JO, Kafa R, Girotra S, Winiecki SK, Fuller CC, Carnahan RM, Leonard CE, Haskins C, Garcia C, Chrischilles EA.

Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):398-404. doi: 10.1002/pds.4398. Epub 2018 Feb 15.

PMID:
29446185
12.

New strategies for the development of lipid-lowering therapies to reduce cardiovascular risk.

Graham I, Shear C, De Graeff P, Boulton C, Catapano AL, Stough WG, Carlsson SC, De Backer G, Emmerich J, Greenfeder S, Kim AM, Lautsch D, Nguyen T, Nissen SE, Prasad K, Ray KK, Robinson JG, Sasiela WJ, Bruins Slot K, Stroes E, Thuren T, Van der Schueren B, Velkovski-Rouyer M, Wasserman SM, Wiklund O, Zouridakis E; European Society of Cardiology Cardiovascular Roundtable .

Eur Heart J Cardiovasc Pharmacother. 2018 Apr 1;4(2):119-127. doi: 10.1093/ehjcvp/pvx031.

PMID:
29194462
13.

Lipid management in contemporary community practice: Results from the Provider Assessment of Lipid Management (PALM) Registry.

Navar AM, Wang TY, Li S, Robinson JG, Goldberg AC, Virani S, Roger VL, Wilson PWF, Elassal J, Lee LV, Peterson ED.

Am Heart J. 2017 Nov;193:84-92. doi: 10.1016/j.ahj.2017.08.005. Epub 2017 Aug 12.

PMID:
29129260
14.

Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.

Fang G, Annis IE, Farley JF, Mahendraratnam N, Hickson RP, Stürmer T, Robinson JG.

Pharmacotherapy. 2018 Jan;38(1):29-41. doi: 10.1002/phar.2051. Epub 2017 Dec 11.

PMID:
29059475
15.

Changes in Statin Adherence Following an Acute Myocardial Infarction Among Older Adults: Patient Predictors and the Association With Follow-Up With Primary Care Providers and/or Cardiologists.

Hickson RP, Robinson JG, Annis IE, Killeya-Jones LA, Korhonen MJ, Cole AL, Fang G.

J Am Heart Assoc. 2017 Oct 19;6(10). pii: e007106. doi: 10.1161/JAHA.117.007106.

16.

Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.

Korhonen MJ, Robinson JG, Annis IE, Hickson RP, Bell JS, Hartikainen J, Fang G.

J Am Coll Cardiol. 2017 Sep 26;70(13):1543-1554. doi: 10.1016/j.jacc.2017.07.783.

PMID:
28935030
17.

Cognitive Function in a Randomized Trial of Evolocumab.

Giugliano RP, Mach F, Zavitz K, Kurtz C, Im K, Kanevsky E, Schneider J, Wang H, Keech A, Pedersen TR, Sabatine MS, Sever PS, Robinson JG, Honarpour N, Wasserman SM, Ott BR; EBBINGHAUS Investigators.

N Engl J Med. 2017 Aug 17;377(7):633-643. doi: 10.1056/NEJMoa1701131.

18.

Metabolic syndrome cluster does not provide incremental prognostic information in patients with stable cardiovascular disease: A post hoc analysis of the AIM-HIGH trial.

Lyubarova R, Robinson JG, Miller M, Simmons DL, Xu P, Abramson BL, Elam MB, Brown TM, McBride R, Fleg JL, Desvigne-Nickens P, Ayenew W, Boden WE; Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides and Impact on Global Health Outcomes (AIM-HIGH) Investigators.

J Clin Lipidol. 2017 Sep - Oct;11(5):1201-1211. doi: 10.1016/j.jacl.2017.06.017. Epub 2017 Jul 5.

PMID:
28807460
19.

Long-term treatment adherence to the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab in 6 ODYSSEY Phase III clinical studies with treatment duration of 1 to 2 years.

Farnier M, Colhoun HM, Sasiela WJ, Edelberg JM, Asset G, Robinson JG.

J Clin Lipidol. 2017 Jul - Aug;11(4):986-997. doi: 10.1016/j.jacl.2017.05.016. Epub 2017 Jun 8.

20.

Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS).

Ammann EM, Pottala JV, Robinson JG, Espeland MA, Harris WS.

Prostaglandins Leukot Essent Fatty Acids. 2017 Jun;121:68-75. doi: 10.1016/j.plefa.2017.06.006. Epub 2017 Jun 15.

21.

What Women (and Clinicians) Don't Know Hurts Them.

Robinson JG.

J Am Coll Cardiol. 2017 Jul 11;70(2):133-135. doi: 10.1016/j.jacc.2017.05.037. Epub 2017 Jun 22. No abstract available.

22.

Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association.

Sacks FM, Lichtenstein AH, Wu JHY, Appel LJ, Creager MA, Kris-Etherton PM, Miller M, Rimm EB, Rudel LL, Robinson JG, Stone NJ, Van Horn LV; American Heart Association.

Circulation. 2017 Jul 18;136(3):e1-e23. doi: 10.1161/CIR.0000000000000510. Epub 2017 Jun 15. Review. Erratum in: Circulation. 2017 Sep 5;136(10 ):e195.

23.

Reply: Cost Effectiveness of Nonstatin-to-Statin Therapy.

Robinson JG.

J Am Coll Cardiol. 2017 Apr 18;69(15):1996. doi: 10.1016/j.jacc.2017.01.056. No abstract available.

24.

Red blood cell polyunsaturated fatty acids and mortality in the Women's Health Initiative Memory Study.

Harris WS, Luo J, Pottala JV, Espeland MA, Margolis KL, Manson JE, Wang L, Brasky TM, Robinson JG.

J Clin Lipidol. 2017 Jan - Feb;11(1):250-259.e5. doi: 10.1016/j.jacl.2016.12.013. Epub 2017 Jan 12.

25.

Clinical Trials Targeting Aging and Age-Related Multimorbidity.

Espeland MA, Crimmins EM, Grossardt BR, Crandall JP, Gelfond JA, Harris TB, Kritchevsky SB, Manson JE, Robinson JG, Rocca WA, Temprosa M, Thomas F, Wallace R, Barzilai N; Multimorbidity Clinical Trials Consortium.

J Gerontol A Biol Sci Med Sci. 2017 Mar 1;72(3):355-361. doi: 10.1093/gerona/glw220.

26.

Planning a Research Agenda to Incorporate Imaging Into Clinical Practice.

Robinson JG.

JACC Cardiovasc Imaging. 2017 Sep;10(9):1039-1041. doi: 10.1016/j.jcmg.2016.12.018. Epub 2017 Mar 15. No abstract available.

PMID:
28330666
27.

Potential for Net Benefit Should Guide Preventive Therapy.

Stone NJ, Robinson JG.

Circulation. 2017 Feb 14;135(7):630-632. doi: 10.1161/CIRCULATIONAHA.116.022147. No abstract available.

28.

Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab: Pooled Data From Randomized Trials.

Robinson JG, Rosenson RS, Farnier M, Chaudhari U, Sasiela WJ, Merlet L, Miller K, Kastelein JJ.

J Am Coll Cardiol. 2017 Feb 7;69(5):471-482. doi: 10.1016/j.jacc.2016.11.037.

29.

Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes.

Ference BA, Robinson JG, Brook RD, Catapano AL, Chapman MJ, Neff DR, Voros S, Giugliano RP, Davey Smith G, Fazio S, Sabatine MS.

N Engl J Med. 2016 Dec 1;375(22):2144-2153.

30.

Serum lipid changes following the onset of depressive symptoms in postmenopausal women.

Persons JE, Robinson JG, Payne ME, Fiedorowicz JG.

Psychiatry Res. 2017 Jan;247:282-287. doi: 10.1016/j.psychres.2016.12.006. Epub 2016 Dec 5.

31.

Determining When to Add Nonstatin Therapy: A Quantitative Approach.

Robinson JG, Huijgen R, Ray K, Persons J, Kastelein JJ, Pencina MJ.

J Am Coll Cardiol. 2016 Dec 6;68(22):2412-2421. doi: 10.1016/j.jacc.2016.09.928. Review.

32.

The future of lipid guidelines.

Robinson JG.

Curr Opin Lipidol. 2016 Dec;27(6):585-591. Review.

PMID:
27676195
33.

Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program).

Gaudet D, Watts GF, Robinson JG, Minini P, Sasiela WJ, Edelberg J, Louie MJ, Raal FJ.

Am J Cardiol. 2017 Jan 1;119(1):40-46. doi: 10.1016/j.amjcard.2016.09.010. Epub 2016 Sep 29.

34.

Safety of Alirocumab (A PCSK9 Monoclonal Antibody) from 14 Randomized Trials.

Jones PH, Bays HE, Chaudhari U, Pordy R, Lorenzato C, Miller K, Robinson JG.

Am J Cardiol. 2016 Dec 15;118(12):1805-1811. doi: 10.1016/j.amjcard.2016.08.072. Epub 2016 Sep 14.

35.

Genetic predisposition to elevated levels of C-reactive protein is associated with a decreased risk for preeclampsia.

Spracklen CN, Smith CJ, Saftlas AF, Triche EW, Bjonnes A, Keating BJ, Saxena R, Breheny PJ, Dewan AT, Robinson JG, Hoh J, Ryckman KK.

Hypertens Pregnancy. 2017 Feb;36(1):30-35. doi: 10.1080/10641955.2016.1223303. Epub 2016 Sep 22.

36.

Nonstatins and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors: Role in Non-Familial Hypercholesterolemia.

Robinson JG.

Prog Cardiovasc Dis. 2016 Sep - Oct;59(2):165-171. doi: 10.1016/j.pcad.2016.07.011. Epub 2016 Aug 4. Review.

PMID:
27498088
37.

No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY Phase 3 studies.

Colhoun HM, Ginsberg HN, Robinson JG, Leiter LA, Müller-Wieland D, Henry RR, Cariou B, Baccara-Dinet MT, Pordy R, Merlet L, Eckel RH.

Eur Heart J. 2016 Oct 14;37(39):2981-2989. Epub 2016 Jul 26.

38.

Low Birth Weight and Risk of Later-Life Physical Disability in Women.

Spracklen CN, Ryckman KK, Robinson JG, Stefanick ML, Sarto GE, Anton SD, Wallace RB.

J Gerontol A Biol Sci Med Sci. 2017 Apr 1;72(4):543-547. doi: 10.1093/gerona/glw134.

39.

Haptoglobin Genotype as a Determinant of Benefit or Harm From Niacin for Participants With Diabetes.

Asleh R, Levy NS, Doros G, Costacou T, Robinson JG, Blum S, Goldenstein H, Boden WE, Simmons DL, Lacy MA, Grunberger G, Anderson TJ, Levy AP.

J Am Coll Cardiol. 2016 May 31;67(21):2553-4. doi: 10.1016/j.jacc.2016.03.533. No abstract available.

40.

Moving Toward the Next Paradigm for Cardiovascular Prevention.

Robinson JG, Ray K.

Circulation. 2016 Apr 19;133(16):1533-6. doi: 10.1161/CIRCULATIONAHA.116.022134. No abstract available.

41.

Evidence-Based Policy Making: Assessment of the American Heart Association's Strategic Policy Portfolio: A Policy Statement From the American Heart Association.

Labarthe DR, Goldstein LB, Antman EM, Arnett DK, Fonarow GC, Alberts MJ, Hayman LL, Khera A, Sallis JF, Daniels SR, Sacco RL, Li S, Ku L, Lantz PM, Robinson JG, Creager MA, Van Horn L, Kris-Etherton P, Bhatnagar A, Whitsel LP; American Heart Association Advocacy Coordinating Committee, Council on Hypertension, Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, Council on Quality of Care and Outcomes Research, Council on Cardiovascular Surgery and Anesthesia, Council on Functional Genomics and Translational Biology, and Council on Epidemiology and Prevention.

Circulation. 2016 May 3;133(18):e615-53. doi: 10.1161/CIR.0000000000000410. Epub 2016 Apr 4. Review.

42.

Effects of Extended-Release Niacin Added to Simvastatin/Ezetimibe on Glucose and Insulin Values in AIM-HIGH.

Goldberg RB, Bittner VA, Dunbar RL, Fleg JL, Grunberger G, Guyton JR, Leiter LA, McBride R, Robinson JG, Simmons DL, Wysham C, Xu P, Boden WE.

Am J Med. 2016 Jul;129(7):753.e13-22. doi: 10.1016/j.amjmed.2016.02.039. Epub 2016 Mar 29.

43.

Lower might be better - It matters how you get there, and in whom.

Robinson JG.

Eur Heart J. 2016 May 1;37(17):1380-3. doi: 10.1093/eurheartj/ehw102. Epub 2016 Mar 29. No abstract available.

PMID:
27026749
45.

Counterpoint: Low-Density Lipoprotein Cholesterol Targets Are Not Needed in Lipid Treatment Guidelines.

Robinson JG, Ray K.

Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):586-90. doi: 10.1161/ATVBAHA.116.306887. Epub 2016 Mar 17.

46.

Longitudinal study of low serum LDL cholesterol and depressive symptom onset in postmenopause.

Persons JE, Robinson JG, Coryell WH, Payne ME, Fiedorowicz JG.

J Clin Psychiatry. 2016 Feb;77(2):212-20. doi: 10.4088/JCP.14m09505.

47.

Association Between Preadmission Functional Status and Use and Effectiveness of Secondary Prevention Medications in Elderly Survivors of Acute Myocardial Infarction.

Chrischilles EA, Schneider KM, Schroeder MC, Letuchy E, Wallace RB, Robinson JG, Brooks JM.

J Am Geriatr Soc. 2016 Mar;64(3):526-35. doi: 10.1111/jgs.13953. Epub 2016 Mar 1.

PMID:
26928940
48.

Red Blood Cell Fatty Acids and Incident Diabetes Mellitus in the Women's Health Initiative Memory Study.

Harris WS, Luo J, Pottala JV, Margolis KL, Espeland MA, Robinson JG.

PLoS One. 2016 Feb 16;11(2):e0147894. doi: 10.1371/journal.pone.0147894. eCollection 2016.

49.

Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data.

Sattar N, Preiss D, Robinson JG, Djedjos CS, Elliott M, Somaratne R, Wasserman SM, Raal FJ.

Lancet Diabetes Endocrinol. 2016 May;4(5):403-10. doi: 10.1016/S2213-8587(16)00003-6. Epub 2016 Feb 8.

PMID:
26868195
50.

Correlates of Successful Aging in Racial and Ethnic Minority Women Age 80 Years and Older: Findings from the Women's Health Initiative.

Cené CW, Dilworth-Anderson P, Leng I, Garcia L, Benavente V, Rosal M, Vaughan L, Coker LH, Corbie-Smith G, Kim M, Bell CL, Robinson JG, Manson JE, Cochrane B.

J Gerontol A Biol Sci Med Sci. 2016 Mar;71 Suppl 1:S87-99. doi: 10.1093/gerona/glv099.

PMID:
26858329

Supplemental Content

Loading ...
Support Center